Procaps Group SA News - PROC

Update on Proposed Acquisition of Grupo Somar

MIAMI and BARRANQUILLA, Colo., Dec. 22, 2022 (GLOBE NEWSWIRE) -- Procaps Group, S.A. (NASDAQ: PROC...

Procaps Group Reports Third Quarter and Nine Months 2022 Results

MIAMI and BARRANQUILLA, Colombia, Nov. 14, 2022 (GLOBE NEWSWIRE) -- Procaps Group S.A. (NASDAQ: PROC...

Procaps Group to Report Third Quarter and Nine Months of 2022 on November 14, 2022

MIAMI and BARRANQUILLA, Colombia, Nov. 08, 2022 (GLOBE NEWSWIRE) -- Procaps Group (NASDAQ: PROC) (“Procaps”...

Procaps Announces ESG Commitments and Initiatives with Inaugural Report

MIAMI and BARRANQUILLA, Colombia, Oct. 11, 2022 (GLOBE NEWSWIRE) -- Procaps Group (NASDAQ: PROC) (“Procaps”...

Procaps Group to Participate in the BTG Pactual LatAm CEO Conference

MIAMI and BARRANQUILLA, Colombia, Oct. 05, 2022 (GLOBE NEWSWIRE) -- Procaps Group (NASDAQ: PROC) (“Procaps”), a leading integrated LatAm...

Procaps Group Reports Second Quarter and First Half 2022 Results

Net Revenues Increased 14% year-over-year in the Second Quarter, with Adjusted EBITDA Margin of 24%Constant currency Net Revenues Increased by 18...

Procaps Group Reports Preliminary First Quarter 2022 Results

MIAMI and BARRANQUILLA, Colombia, June 02, 2022 (GLOBE NEWSWIRE) -- Procaps Group S.A. (NASDAQ: PROC) (“Procaps”), a leading integrated LatAm...

Brookline Capital Markets Reiterates a Buy Rating on Procaps Group (PROC)

In a report released today, Kemp Dolliver from Brookline Capital Markets reiterated a Buy rating on Procaps Group (PROC – Research Report), with a...

Procaps Group to Acquire Grupo Somar (including Química y Farmacia, Gelcaps and related entities) from Advent International, gaining an important presence in Mexico, the Region's Second Largest Market

This acquisition reaffirms Procaps Groups’ strategy to become one of the fastest growing pharmaceutical organizations in Latin America With FY2021...

Procaps Group Announces Capacity Expansion Plans in the United States with Construction of New Gummy Manufacturing Facility in Florida

New Funtrition Gummy Manufacturing Facility in Florida Slated to be Fully Operational by Q1 2023 Production Facility to Support Increased U.S...

Procaps Group Announces Appointment of Melissa Angelini as Investor Relations Director

Pharmaceutical Industry and Investor Relations Veteran to Lead Capital Markets Communications...

Boards:

Quotes:

Boards

News

Market Data

Markets

Discover

Procaps Group SA (PROC)

Professional-Grade Tools, for Individual Investors.

PROC News

Update on Proposed Acquisition of Grupo Somar

Procaps Group Reports Third Quarter and Nine Months 2022 Results

Procaps Group to Report Third Quarter and Nine Months of 2022 on November 14, 2022

Procaps Announces ESG Commitments and Initiatives with Inaugural Report

Procaps Group to Participate in the BTG Pactual LatAm CEO Conference

Procaps Group Reports Second Quarter and First Half 2022 Results

Procaps Group Reports Preliminary First Quarter 2022 Results

Brookline Capital Markets Reiterates a Buy Rating on Procaps Group (PROC)

Procaps Group to Acquire Grupo Somar (including Química y Farmacia, Gelcaps and related entities) from Advent International, gaining an important presence in Mexico, the Region's Second Largest Market

Brookline Capital Markets Sticks to Its Buy Rating for Procaps Group (PROC)

Brookline Capital Markets Reaffirms Their Buy Rating on Procaps Group (PROC)

Procaps Group Reports Fourth Quarter and Fiscal Year 2021 Financial Results

Amended Statement of Ownership (sc 13g/a)

Procaps Group Announces Capacity Expansion Plans in the United States with Construction of New Gummy Manufacturing Facility in Florida

Procaps Group Announces Appointment of Melissa Angelini as Investor Relations Director

PROC Discussion

Your Recent History

Boards:

Quotes:

Boards

News

Market Data

Markets

Discover

Procaps Group SA (PROC) News

Procaps Group SA (PROC)

Professional-Grade Tools, for Individual Investors.

PROC News

Update on Proposed Acquisition of Grupo Somar

Procaps Group Reports Third Quarter and Nine Months 2022 Results

Procaps Group to Report Third Quarter and Nine Months of 2022 on November 14, 2022

Procaps Announces ESG Commitments and Initiatives with Inaugural Report

Procaps Group to Participate in the BTG Pactual LatAm CEO Conference

Procaps Group Reports Second Quarter and First Half 2022 Results

Procaps Group Reports Preliminary First Quarter 2022 Results

Brookline Capital Markets Reiterates a Buy Rating on Procaps Group (PROC)

Procaps Group to Acquire Grupo Somar (including Química y Farmacia, Gelcaps and related entities) from Advent International, gaining an important presence in Mexico, the Region's Second Largest Market

Brookline Capital Markets Sticks to Its Buy Rating for Procaps Group (PROC)

Brookline Capital Markets Reaffirms Their Buy Rating on Procaps Group (PROC)

Procaps Group Reports Fourth Quarter and Fiscal Year 2021 Financial Results

Amended Statement of Ownership (sc 13g/a)

Procaps Group Announces Capacity Expansion Plans in the United States with Construction of New Gummy Manufacturing Facility in Florida

Procaps Group Announces Appointment of Melissa Angelini as Investor Relations Director

PROC Discussion

Your Recent History